Using patented CELLg8 liposomal delivery technology and a clinically researched extract of French melon, this advanced formula is designed to significantly increase the bodys cellular concentrations of glutathione (GPx), superoxide dismutase (SOD) and catalase (CAT) the three primary antioxidants at the foundation of cellular health, detoxification and longevity
The primary therapeutic indication for GLP-1 agonists in the UK is type 2 diabetes management, with some formulations also licensed for weight management
However, use it only for laboratory research
A Missense Variant in GLP1R Gene Is Associated with the Glycaemic Response to Treatment with Gliptins. Jensterle, Mojca, et al
This resulted in severe vomiting, stomach pain and gastrointestinal burning
We find that the loss of GCLC across all tissues of adult animals results in rapid weight loss and death